WO2004108899A3 - Pni microarray and uses - Google Patents

Pni microarray and uses Download PDF

Info

Publication number
WO2004108899A3
WO2004108899A3 PCT/US2004/017686 US2004017686W WO2004108899A3 WO 2004108899 A3 WO2004108899 A3 WO 2004108899A3 US 2004017686 W US2004017686 W US 2004017686W WO 2004108899 A3 WO2004108899 A3 WO 2004108899A3
Authority
WO
WIPO (PCT)
Prior art keywords
pni
microarray
psychoneuroendocrinimmune
microarrays
compositions
Prior art date
Application number
PCT/US2004/017686
Other languages
French (fr)
Other versions
WO2004108899A2 (en
Inventor
Ainsley Nicholson
Suzanne D Vernon
Original Assignee
Us Gov Health & Human Serv
Ainsley Nicholson
Suzanne D Vernon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Ainsley Nicholson, Suzanne D Vernon filed Critical Us Gov Health & Human Serv
Priority to AU2004245998A priority Critical patent/AU2004245998A1/en
Priority to CA002528162A priority patent/CA2528162A1/en
Publication of WO2004108899A2 publication Critical patent/WO2004108899A2/en
Publication of WO2004108899A3 publication Critical patent/WO2004108899A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Disclosed are compositions and methods for microarrays comprising genes involved in psychoneuroendocrinimmune (PNI) activity.
PCT/US2004/017686 2003-06-04 2004-06-04 Pni microarray and uses WO2004108899A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2004245998A AU2004245998A1 (en) 2003-06-04 2004-06-04 PNI microarray and uses
CA002528162A CA2528162A1 (en) 2003-06-04 2004-06-04 Pni microarray and uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47591503P 2003-06-04 2003-06-04
US60/475,915 2003-06-04

Publications (2)

Publication Number Publication Date
WO2004108899A2 WO2004108899A2 (en) 2004-12-16
WO2004108899A3 true WO2004108899A3 (en) 2007-04-26

Family

ID=33511730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017686 WO2004108899A2 (en) 2003-06-04 2004-06-04 Pni microarray and uses

Country Status (3)

Country Link
AU (1) AU2004245998A1 (en)
CA (1) CA2528162A1 (en)
WO (1) WO2004108899A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11965029B2 (en) 2021-06-04 2024-04-23 Amgen Inc. ST2 antigen binding proteins

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1603585A2 (en) 2003-03-14 2005-12-14 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1538219A1 (en) * 2003-12-04 2005-06-08 Erasmus University Medical Center Rotterdam Method to diagnose or screen for type 1 diabetes mellitus
ES2547381T3 (en) 2004-04-09 2015-10-05 Monsanto Technology, Llc Compositions and procedures for controlling insect infestations in plants
WO2005114206A2 (en) * 2004-05-13 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a)
WO2006029184A2 (en) 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US7794933B1 (en) 2005-01-04 2010-09-14 Myriad Genetics, Inc. Depression-related gene
WO2006078911A2 (en) * 2005-01-19 2006-07-27 Genzyme Corporation Gitr antibodies for the diagnosis of nsclc
EP1865981A2 (en) * 2005-04-07 2007-12-19 Chiron Corporation Cacna1e in cancer diagnosis, detection and treatment
GB0515685D0 (en) * 2005-07-29 2005-09-07 Imp College Innovations Ltd Test
EP1930445B1 (en) * 2005-09-02 2010-03-31 Toray Industries, Inc. Kit and method for detection of urothelial cancer
RU2478710C2 (en) * 2005-09-16 2013-04-10 Монсанто Текнолоджи Ллс Methods for genetic control insect infestation in plants and compositions used therefor
US20100029504A1 (en) * 2007-01-16 2010-02-04 Phigenix, Inc. Detecting pax2 for the diagnosis of breast cancer
US20070237713A1 (en) 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
WO2008021431A2 (en) * 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2008087205A1 (en) * 2007-01-19 2008-07-24 Integragen Human diabetes susceptibility sema6d gene
EP2009112A1 (en) * 2007-06-25 2008-12-31 Universität Duisburg-Essen Screening-method for polymorphic markers in HtrA1 gene in neurodegenerative disorders
US20110212075A1 (en) * 2007-06-25 2011-09-01 Siemens Aktiengesellschaft Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders
US9150860B2 (en) 2008-07-22 2015-10-06 The General Hospital Corporation FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
WO2010141999A1 (en) * 2009-06-12 2010-12-16 The University Of Queensland Agents and methods for diagnosing and treating ankylosing spondylitis
EP2561363B1 (en) 2010-04-21 2021-07-14 Memed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
US20130143954A1 (en) * 2010-06-24 2013-06-06 Genomictree, Inc. Recombinant vector for suppressing proliferation of human papilloma virus cells including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papilloma virus
FR2971258B1 (en) 2011-02-09 2020-12-04 Bio Rad Pasteur COMBINATION OF BIOMARKERS FOR THE PROGNOSIS OF A RESPONSE OR NON-RESPONSE TO ANTI-HCV TREATMENT
EP2812700B1 (en) 2012-02-09 2018-04-18 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
AR091069A1 (en) 2012-05-18 2014-12-30 Amgen Inc PROTEINS OF UNION TO ANTIGEN DIRECTED AGAINST THE ST2 RECEIVER
CN103966155B (en) * 2013-04-25 2016-03-02 苏州吉诺瑞生物科技有限公司 Method for transfecting protein or compound by using self-assembled cell chip
CA2954601C (en) 2014-08-14 2023-04-18 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
WO2016059636A1 (en) 2014-10-14 2016-04-21 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
US11466331B2 (en) 2016-03-03 2022-10-11 Memed Diagnostics Ltd. RNA determinants for distinguishing between bacterial and viral infections
EP3907292A1 (en) 2016-03-03 2021-11-10 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
WO2017197141A2 (en) * 2016-05-13 2017-11-16 Sangamo Therapeutics, Inc. Targeted treatment of androgenic alopecia
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
EP3482201B1 (en) 2016-07-10 2022-12-14 Memed Diagnostics Ltd. Early diagnosis of infections
JP7084580B2 (en) * 2016-09-23 2022-06-15 株式会社Ｄｎａチップ研究所 How to detect mood disorders
CN110073220A (en) 2016-09-29 2019-07-30 米密德诊断学有限公司 The method of risk assessment and classification of diseases
US11385241B2 (en) 2016-09-29 2022-07-12 Memed Diagnostics Ltd. Methods of prognosis and treatment
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN110863066A (en) * 2019-11-21 2020-03-06 廊坊诺道中科医学检验实验室有限公司 Kit for detecting five TORCH pathogens and application thereof
WO2023056193A2 (en) * 2021-09-29 2023-04-06 Chimera Bioengineering, Inc. Il-18 variants and uses thereof
CN116515993A (en) * 2023-06-25 2023-08-01 广州凯普医药科技有限公司 Primer group and kit for detecting drug genes for depression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KUROMITSU J. ET AL.: "Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder", GENE EXPRESSION PATTERNS, vol. 1, 2001, pages 17 - 21, XP003010764 *
SHOEMAKER D.D. ET AL.: "Recent developments in DNA microarrays", CURRENT OPINION IN MICROBIOLOGY, vol. 5, 2002, pages 334 - 337, XP001182646 *
WEINDRUCH R. ET AL.: "Gene expression profiling of aging using DNA microarrays", MECHANISMS OF AGEING AND DEVELOPMENT, vol. 123, 2002, pages 177 - 193, XP002304151 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11965029B2 (en) 2021-06-04 2024-04-23 Amgen Inc. ST2 antigen binding proteins

Also Published As

Publication number Publication date
CA2528162A1 (en) 2004-12-16
AU2004245998A1 (en) 2004-12-16
WO2004108899A2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
WO2004108899A3 (en) Pni microarray and uses
IL237721B (en) Nucleic acid-lipid particles comprising interfering rna, compositions comprising same and uses thereof
AU2003290597A1 (en) Modified oligonucleotides for use in rna interference
AU2003225644A1 (en) Wax ester synthase dna sequence, protein and uses thereof
AU2003239129A1 (en) Methods and compositions for dna manipulation
WO2006020768A3 (en) Chemically modified oligonucleotides
ZA200608721B (en) Methods and compositions for analyzing ahasl genes
ZA200801235B (en) Novel gene disruptions, compositions and methods relating thereto
WO2006074351A3 (en) Reversible nucleotide terminators and uses thereof
EP1838875A4 (en) Compositions and methods for modulating gene expression using self-protected oligonucleotides
ZA200609573B (en) Griffithsin, Glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
AU2003254597A1 (en) Dna chip based genetic typing
EP1869211A4 (en) Multiple snp for diagnosing colorectal cancer, microarray and kit comprising the same, and method of diagnosing colorectal cancer using the same
AU2003220387A1 (en) Gene amplification in cancer
PL376971A1 (en) Amplified genes involved in cancer
AU2003234198A8 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
EP1713918A4 (en) Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray
AU2005270917A8 (en) Gastrin-specific interfering RNA
AU2003296087A1 (en) Nucleotide derivatives and dna microarray
WO2005082088A3 (en) Functional genomics and gene trapping in haploid or hypodiploid cells
AU2003299467A1 (en) Canine gene microarrays
AU2003901105A0 (en) Improved heap leach
AU2003222173A1 (en) Nucleic acid compositions and methods for use
AU2003277902A8 (en) Acc gene
AU2002350599A1 (en) Homeotic genes and proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2528162

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004245998

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004754315

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 84/DELNP/2006

Country of ref document: IN

WWW Wipo information: withdrawn in national office

Ref document number: 2004754315

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004245998

Country of ref document: AU

Date of ref document: 20040604

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004245998

Country of ref document: AU